Concert Pharmaceuticals Inc. sell StockNews.com
Start price
12.03.23
/
50%
€7.88
Target price
12.03.24
-
Performance (%)
0.00%
End price
13.03.24
-
Summary
This prediction is currently being closed. The SELL prediction by StockNews_com is currently unchanged from the start price. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Concert Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | -2,12 % | -7,97 % | -1,73 % | 53,34 % |
| iShares Nasdaq 100 | -1,32 % | -0,07 % | 16,60 % | 81,16 % |
| iShares Nikkei 225® | -0,32 % | -6,38 % | 25,63 % | 52,30 % |
| iShares S&P 500 | -1,57 % | -1,97 % | 10,83 % | 60,91 % |
Comments by StockNews_com for this prediction
In the thread Concert Pharmaceuticals Inc. diskutieren
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for CNCE provided by MarketBeat
In the thread Trading Concert Pharmaceuticals Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten